Primary Sjögren's syndrome and malignancy risk: A systematic review and meta-analysis

Annals of the Rheumatic Diseases

Volumn 73, Issue 6, 2014, Pages 1151-1156

  Liang, Yan ^a   Yang, Zaixing ^a   Qin, Baodong ^a   Zhong, Renqian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS (TOPIC); NONHODGKIN LYMPHOMA; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SJOEGREN SYNDROME; SOLID TUMOR; SYSTEMATIC REVIEW (TOPIC); THYROID CANCER; FEMALE; MALE; MALIGNANCY; META ANALYSIS; MULTIPLE MYELOMA; NEOPLASM; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; THYROID TUMOR;

MALIGNANCY; META-ANALYSIS; SYSTEMATIC REVIEW;

FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MULTIPLE MYELOMA; NEOPLASMS; RISK FACTORS; SJOGREN'S SYNDROME; THYROID NEOPLASMS;

EID: 84899945310     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203305     Document Type: Article

References (24)

1. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, et al. Primary Sjogren syndrome. BMJ 2012;344:e3821.
2. Fox RI. Sjögren's syndrome. Lancet 2005;366: 321-31.
3. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89: 888-92. (Pubitemid 9087322)
4. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005;165: 2337-44. (Pubitemid 41640845)
5. Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology 2012;56: 1409-17.
6. Taeger D, Sun Y, Keil U, et al. A stand-alone Windows application for computing extract person-years, standardized mortality ratios and confidence intervals in epidemiological studies. Epidemiology 2000;11: 607-8. (Pubitemid 30660042)
7. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21: 589-624.
8. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988;7: 889-94.
9. Egger M, Davey SG, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315: 629-34. (Pubitemid 27387172)
10. Landgren AM, Landgren O, Gridley G, et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011;117: 1163-71.
11. Thomas E, Brewster DH, Black RJ, et al. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000;88: 497-502.
12. Valesini G, Priori R, Bavoillot D, et al. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. J Rheumatol 1997;24: 2376-80. (Pubitemid 28005139)
13. Kauppi M, Pukkala E, Isomäki H. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997;8: 201-4. (Pubitemid 27170375)
14. Pertovaara M, Pukkala E, Laippala P, et al. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 2001;60: 467-72. (Pubitemid 32417418)
15. Davidson BK, Kelly CA, Griffiths ID. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology (Oxford) 1999;38: 245-53. (Pubitemid 29507160)
16. Lazarus MN, Robinson D, Mak V, et al. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2006;45: 1012-15. (Pubitemid 44283059)
17. Theander E, Henriksson G, Ljungberg O, et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65: 796-803. (Pubitemid 43799181)
18. Zhang W, Feng S, Yan S, et al. Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort. Rheumatology (Oxford) 2010;49: 571-7.
19. Solans-Laqué R, López-Hernandez A, Bosch-Gil JA, et al. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome. Semin Arthritis Rheum 2011;41: 415-23.
20. Johnsen SJ, Brun JG, Gøransson LG, et al. The risk of non-Hodgkin lymphoma in primary Sjögren's syndrome, a population-based study. Arthritis Care Res (Hoboken). Published Online First 8 Nov 2012. doi:10.1002/acr.21887.
21. Hemminki K, Liu X, Ji J, et al. Effect of autoimmune diseases on risk and survival in female cancers. Gynecol Oncol 2012;127: 180-5.
22. Weng MY, Huang YT, Liu MF, et al. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan. Ann Rheum Dis 2012;71: 524-7.
23. Sterne J, Becker B, Egger M. The funnel plot. In: Rothstein H, Sutton A, Borenstein M. eds. Publication bias in meta-analysis. Prevention, assessment and adjustments. Chichester: Wiley, 2005: 75-98.
24. Ma Y, Zhang P, Wang F, et al. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 2011;29: 3775-82.